Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Champions Oncology Other Long-Term Assets 2010-2025 | CSBR

Champions Oncology other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  
Champions Oncology Annual Other Long-Term Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Champions Oncology Quarterly Other Long-Term Assets
(Millions of US $)
2025-01-31 $0
2024-10-31 $0
2024-07-31 $0
2024-04-30 $0
2024-01-31 $0
2023-10-31 $0
2023-07-31 $0
2023-04-30 $0
2023-01-31 $0
2022-10-31 $0
2022-07-31 $0
2022-04-30 $0
2022-01-31 $0
2021-10-31 $0
2021-07-31 $0
2021-04-30 $0
2021-01-31 $0
2020-10-31 $0
2020-07-31 $0
2020-04-30 $0
2020-01-31 $0
2019-10-31 $0
2019-07-31 $0
2019-04-30 $0
2019-01-31 $0
2018-10-31 $0
2018-07-31 $0
2018-04-30 $0
2018-01-31 $0
2017-10-31 $0
2017-07-31 $0
2017-04-30 $0
2017-01-31 $0
2016-10-31 $0
2016-07-31 $0
2016-04-30 $0
2016-01-31 $0
2015-10-31 $0
2015-07-31 $0
2015-04-30 $0
2015-01-31 $0
2014-10-31 $0
2014-07-31 $0
2014-04-30 $0
2014-01-31 $0
2013-10-31 $0
2013-07-31 $0
2013-04-30 $0
2013-01-31 $0
2012-10-31 $0
2012-07-31 $0
2012-04-30 $0
2012-01-31 $0
2011-10-31 $0
2011-07-31
2011-04-30
2011-01-31
2010-10-31
2010-07-31
2010-04-30
2010-01-31
2009-10-31
2009-07-31
2009-04-30
2009-01-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.099B $0.050B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.617B 35.49
Zoetis (ZTS) United States $69.783B 26.42
Daiichi Sankyo, - (DSNKY) Japan $48.948B 24.90
Takeda Pharmaceutical (TAK) Japan $48.651B 10.77
Sandoz Group AG (SDZNY) Switzerland $19.087B 0.00
Merck (MKKGY) Germany $17.919B 14.83
Summit Therapeutics (SMMT) United States $17.913B 0.00
Shionogi (SGIOY) Japan $14.172B 14.20
United Therapeutics (UTHR) United States $13.667B 12.10
Neurocrine Biosciences (NBIX) United States $10.655B 32.73
IPSEN (IPSEY) France $9.454B 0.00
Orion OYJ (ORINY) Finland $8.841B 23.91
Corcept Therapeutics (CORT) United States $7.622B 57.97
Madrigal Pharmaceuticals (MDGL) United States $7.414B 0.00
Stevanato Group S.p.A (STVN) Italy $6.317B 40.12
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $4.882B 0.00
Grifols, S.A (GRFS) Spain $4.779B 0.00
Soleno Therapeutics (SLNO) United States $3.736B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.126B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.962B 12.02
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.374B 14.73
Hypermarcas (HYPMY) Brazil $2.350B 15.46
Recursion Pharmaceuticals (RXRX) United States $2.247B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.101B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.851B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.826B 0.00
Indivior (INDV) United States $1.587B 6.73
Guardian Pharmacy Services (GRDN) United States $1.585B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
ARS Pharmaceuticals (SPRY) United States $1.372B 174.62
Dyne Therapeutics (DYN) United States $1.340B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Ardelyx (ARDX) United States $1.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.126B 45.78
Enliven Therapeutics (ELVN) United States $0.929B 0.00
Harrow (HROW) United States $0.909B 0.00
Collegium Pharmaceutical (COLL) United States $0.867B 4.61
Avadel Pharmaceuticals (AVDL) Ireland $0.859B 0.00
Xencor (XNCR) United States $0.784B 0.00
Cronos Group (CRON) Canada $0.725B 0.00
Xeris Biopharma Holdings (XERS) United States $0.715B 0.00
AleAnna (ANNA) United States $0.690B 0.00
KalVista Pharmaceuticals (KALV) United States $0.685B 0.00
Akebia Therapeutics (AKBA) United States $0.631B 0.00
Organogenesis (ORGO) United States $0.623B 0.00
Bioventus (BVS) United States $0.599B 15.55
Relay Therapeutics (RLAY) United States $0.568B 0.00
Savara (SVRA) United States $0.553B 0.00
USANA Health Sciences (USNA) United States $0.530B 11.37
Regulus Therapeutics (RGLS) United States $0.529B 0.00
Verve Therapeutics (VERV) United States $0.505B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.489B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Tourmaline Bio (TRML) United States $0.442B 0.00
Elite Pharmaceuticals (ELTP) United States $0.442B 0.00
Altimmune (ALT) United States $0.404B 0.00
Zevra Therapeutics (ZVRA) United States $0.401B 0.00
Siga Technologies (SIGA) United States $0.394B 6.73
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Heron Therapeutics (HRTX) United States $0.369B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.349B 20.81
CytoDyn (CYDY) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.291B 0.00
ProKidney (PROK) United States $0.259B 0.00
Avita Medical (RCEL) United States $0.256B 0.00
Nature's Sunshine Products (NATR) United States $0.228B 26.78
Wellgistics Health (WGRX) United States $0.225B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.198B 24.99
MediWound (MDWD) Israel $0.191B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Larimar Therapeutics (LRMR) United States $0.170B 0.00
Inhibikase Therapeutics (IKT) United States $0.168B 0.00
Korro Bio (KRRO) United States $0.167B 0.00
Nanobiotix S.A (NBTX) France $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.159B 0.00
4D Molecular Therapeutics (FDMT) United States $0.156B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.151B 46.62
Profound Medical (PROF) Canada $0.150B 0.00
Aclaris Therapeutics (ACRS) United States $0.149B 0.00
Nektar Therapeutics (NKTR) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Protara Therapeutics (TARA) United States $0.135B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.130B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.116B 0.00
VAXART, INC (VXRT) United States $0.100B 0.00
OptiNose (OPTN) United States $0.094B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Achieve Life Sciences (ACHV) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.067B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Fractyl Health (GUTS) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 7.86
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.79
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.10
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00